Clinical Trial Update: Seven Versus Fourteen Days of Treatment in Uncomplicated Staphylococcus Aureus Bacteremia [Phase 4]

View source ↗

Summary

A Phase 4 trial update comparing seven versus fourteen days of treatment for uncomplicated Staphylococcus aureus bacteremia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Bacteremia

Snippet

Sponsor: Thomas Benfield | Conditions: Staphylococcus Aureus Bacteremia | Phase 4 | Status: UNKNOWN